Exelixis
EXEL
#1728
Rank
$11.76 B
Marketcap
$43.88
Share price
-0.36%
Change (1 day)
19.63%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company